Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Chaozhi Bu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi, China. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Intestinal Mucosa, Inflammation, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Wuxi health Commission, Top medical expert team of Wuxi Taihu Talent Program.
Abstract (Originalsprache)
Intestinal dysbiosis is believed to play a role in the development of necrotizing enterocolitis (NEC). The efficacy of JNK‐inhibitory peptide (CPJIP) in treating NEC was assessed. Treatment with CPJIP led to a notable reduction in p‐JNK expression in IEC‐6 cells and NEC mice. Following LPS stimulation, the expression of RNA and protein of claudin‐1, claudin‐3, claudin‐4 and occludin was significantly decreased, with this decrease being reversed by CPJIP administration, except for claudin‐3, which remained consistent in NEC mice. Moreover, the expression levels of the inflammatory factors TNF‐α, IL‐1β and IL‐6 were markedly elevated, a phenomenon that was effectively mitigated by the addition of CPJIP in both IEC‐6 cells and NEC mice. CPJIP administration resulted in improved survival rates, ameliorated microscopic intestinal mucosal injury, and increased the total length of the intestines and colon in NEC mice. Additionally, CPJIP treatment led to a reduction in serum concentrations of FD‐4, D‐lactate and DAO. Furthermore, our results revealed that CPJIP effectively inhibited intestinal cell apoptosis and promoted cell proliferation in the intestine. This study represents the first documentation of CPJIP's ability to enhance the expression of tight junction components, suppress inflammatory responses, and rescue intestinal cell fate by inhibiting JNK activation, ultimately mitigating intestinal severity. These findings suggest that CPJIP has the potential to serve as a promising candidate for the treatment of NEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi, China.
- State Key Laboratory of Reproductive Medicine, Research Institute for Reproductive Health and Genetic Diseases, Wuxi Maternity and Child Health Care Hospital, Women's Hospital of Jiangnan University, Jiangnan University…
- Department of Neonatology, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
- Department of Gastroenterology and Digestive Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
ORCID-Profile: Le Zhang
Förderung
- National Natural Science Foundation of China
- Project of Wuxi health Commission
- Top medical expert team of Wuxi Taihu Talent Program
- Medical Key Discipline Program of Wuxi Health Commission
- Wuxi Science and Technology Development Fund
- Top Talent Support Program for young and middle-aged people of Wuxi Health Committee
- the 333 project of Jiangsu Province in 2022
Zitieren
APA
Bu, C., Hu, M., Su, Y., Yuan, F., Zhang, Y., Xia, J., Jia, Z., & Zhang, L. (2024). Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18534
Vancouver
Bu C, Hu M, Su Y, Yuan F, Zhang Y, Xia J, et al. Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18534
BibTeX
@article{Bu2024,
author = {Bu, Chaozhi and Hu, Mengyuan and Su, Yinglin and Yuan, Fuqiang and Zhang, Yiting and Xia, Jing and Jia, Zhenyu and Zhang, Le},
title = {Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18534}
}
EUVIMED